Rush DK - Search Results

1

Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease.

Fink DM, Bores GM, Effland RC, Huger FP, Kurys BE, Rush DK, Selk DE. Fink DM, et al. Among authors: rush dk. J Med Chem. 1995 Sep 1;38(18):3645-51. doi: 10.1021/jm00018a025. J Med Chem. 1995. PMID: 7658452

2

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.

Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW Jr, Davis L, Vargas HM. Bores GM, et al. Among authors: rush dk. J Pharmacol Exp Ther. 1996 May;277(2):728-38. J Pharmacol Exp Ther. 1996. PMID: 8627552

3

Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM. Smith CP, et al. Among authors: rush dk. J Pharmacol Exp Ther. 1997 Feb;280(2):710-20. J Pharmacol Exp Ther. 1997. PMID: 9023283

4

Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl)benzeneethanamine++ + and related analogs as noncompetitive NMDA antagonists with neuroprotective properties.

Martin LL, Lee GE, Lee TB, Rush DK, Wilmot CA, Paulus E, Elben U, Grome JJ, Porsche-Wiebking E, Rudolphi KA, et al. Martin LL, et al. Among authors: rush dk. J Med Chem. 1994 Sep 16;37(19):3008-15. doi: 10.1021/jm00045a004. J Med Chem. 1994. PMID: 7932522

5

3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia.

Hrib NJ, Jurcak JG, Bregna DE, Dunn RW, Geyer HM 3rd, Hartman HB, Roehr JE, Rogers KL, Rush DK, Szczepanik AM, et al. Hrib NJ, et al. Among authors: rush dk. J Med Chem. 1992 Jul 10;35(14):2712-5. doi: 10.1021/jm00092a024. J Med Chem. 1992. PMID: 1353116 No abstract available.

6

Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists.

Dunn RW, Corbett R, Martin LL, Payack JF, Laws-Ricker L, Wilmot CA, Rush DK, Cornfeldt ML, Fielding S. Dunn RW, et al. Among authors: rush dk. Prog Clin Biol Res. 1990;361:495-512. Prog Clin Biol Res. 1990. PMID: 1981268

7

Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic?

Rush DK, Aschmies S, Merriman MC. Rush DK, et al. Neurobiol Aging. 1992 Sep-Oct;13(5):591-4. doi: 10.1016/0197-4580(92)90061-2. Neurobiol Aging. 1992. PMID: 1281289

8

The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.

Szewczak MR, Corbett R, Rush DK, Wilmot CA, Conway PG, Strupczewski JT, Cornfeldt M. Szewczak MR, et al. Among authors: rush dk. J Pharmacol Exp Ther. 1995 Sep;274(3):1404-13. J Pharmacol Exp Ther. 1995. PMID: 7562515

9

Effects of chronic intrahippocampal infusion of lipopolysaccharide in the rat.

Szczepanik AM, Fishkin RJ, Rush DK, Wilmot CA. Szczepanik AM, et al. Among authors: rush dk. Neuroscience. 1996 Jan;70(1):57-65. doi: 10.1016/0306-4522(95)00296-u. Neuroscience. 1996. PMID: 8848136

10

Preclinical anticonvulsant and neuroprotective profile of 8319, a non-competitive NMDA antagonist.

Fielding S, Wilker JC, Chernack J, Ramirez V, Wilmot CA, Martin LL, Payack JF, Cornfeldt ML, Rudolphi KA, Rush DK. Fielding S, et al. Among authors: rush dk. Prog Clin Biol Res. 1990;361:533-41. Prog Clin Biol Res. 1990. PMID: 2290851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters